Wikipedia -WSS

Wikipedia

author：explore 2025-08-12 08:26:15 - browse：4311

What is the best way to fix faulty blood cells, and do so for the most people? That’s the question a horde of gene editing researchers are chasing. A new paper in Science offers an idea.

Researchers loaded up lipid nanoparticles, the tiny clusters of fat, with cellular instruction manuals in the form of mRNA — the same basic construction as the Covid mRNA vaccines. The surface of these therapeutic bundles were decorated with antibodies that guide them to hematopoietic stem cells in the bone marrow. Once there, they delivered gene editing technology packed into the mRNA and corrected sickle cell defects in mice and in human cells.

“What really struck me was, damn, how efficient it is,” said Paula Cannon, a gene therapy researcher at the University of Southern California’s Keck School of Medicine who was not involved with the paper.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Organ aging and disease risk measured by new blood test

WSS

What to do when lifesaving products contribute to climate change

The EPA's new lead rule: How one expert crunched the numbers

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Rep. Raul Ruiz on the physician shortage and more

Rep. Raul Ruiz on the physician shortage and more

leisure time

Wikipedia

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: CAR

Medical records are filled with copy

What don’t we know about an Alzheimer’s drug side effect?

New air purifier tech could be key to improving indoor air quality

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Alkermes shareholders re

Boston's new lab space is opening empty

Tori Bowie and the unacceptable rates of Black maternal death

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

leisure time

WuXi out of biotech trade group, U.S. and China relations to blame

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Organ aging and disease risk measured by new blood test

CDC director unscathed in first congressional testimony

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Rep. Raul Ruiz on the physician shortage and more

entertainment

focus

leisure time

Wikipedia